These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 22084250)

  • 41. Contrasting glycosylation profiles between Fab and Fc of a human IgG protein studied by electrospray ionization mass spectrometry.
    Mimura Y; Ashton PR; Takahashi N; Harvey DJ; Jefferis R
    J Immunol Methods; 2007 Sep; 326(1-2):116-26. PubMed ID: 17714731
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analytical characterization of IgG Fc subclass variants through high-resolution separation combined with multiple LC-MS identification.
    He XA; Washburn N; Arevalo E; Robblee JH
    Anal Bioanal Chem; 2015 Sep; 407(23):7055-66. PubMed ID: 26231686
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Conformational implications of an inversed pH-dependent antibody aggregation.
    Perico N; Purtell J; Dillon TM; Ricci MS
    J Pharm Sci; 2009 Sep; 98(9):3031-42. PubMed ID: 18803243
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Interaction between CH2 and CH3-domains of human immunoglobulin G1 in glycosylated and aglycosylated Fc-fragments].
    Tishchenko VM
    Biofizika; 1999; 44(5):811-2. PubMed ID: 10624519
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biophysical evaluation of hybrid Fc fusion protein of hGH to achieve basal buffer system.
    Kim NA; An IB; Lim HS; Yang SI; Jeong SH
    Int J Pharm; 2016 Nov; 513(1-2):421-430. PubMed ID: 27659863
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of deglycosylation and thermal stress on conformational stability of a full length murine IgG2a monoclonal antibody: observations from molecular dynamics simulations.
    Wang X; Kumar S; Buck PM; Singh SK
    Proteins; 2013 Mar; 81(3):443-60. PubMed ID: 23065923
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Traces of pFc' in IVIG interact with human IgG Fc domains and counteract aggregation.
    Rispens T; Himly M; Ooievaar-De Heer P; den Bleker TH; Aalberse RC
    Eur J Pharm Sci; 2010 Apr; 40(1):62-8. PubMed ID: 20211252
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Construction of a stability landscape of the CH3 domain of human IgG1 by combining directed evolution with high throughput sequencing.
    Traxlmayr MW; Hasenhindl C; Hackl M; Stadlmayr G; Rybka JD; Borth N; Grillari J; Rüker F; Obinger C
    J Mol Biol; 2012 Oct; 423(3):397-412. PubMed ID: 22846908
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recognition of IgG by Fcgamma receptor. The role of Fc glycosylation and the binding of peptide inhibitors.
    Radaev S; Sun PD
    J Biol Chem; 2001 May; 276(19):16478-83. PubMed ID: 11297533
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Conformation, pH-induced conformational changes, and thermal unfolding of anti-p24 (HIV-1) monoclonal antibody CB4-1 and its Fab and Fc fragments.
    Welfle K; Misselwitz R; Hausdorf G; Höhne W; Welfle H
    Biochim Biophys Acta; 1999 Apr; 1431(1):120-31. PubMed ID: 10209285
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Comparative study of conformation properties of Fc-fragments of human immunoglobulin G subclasses using 1H-NMR].
    Khristoforov VS; Kutyshenko VP; Abramov VM; Zav'ialov VP
    Bioorg Khim; 1986 Nov; 12(11):1469-77. PubMed ID: 3801067
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeting a homogeneously glycosylated antibody Fc to bind cancer cells using a synthetic receptor ligand.
    Xiao J; Chen R; Pawlicki MA; Tolbert TJ
    J Am Chem Soc; 2009 Sep; 131(38):13616-8. PubMed ID: 19728704
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Competing aggregation pathways for monoclonal antibodies.
    Wu H; Kroe-Barrett R; Singh S; Robinson AS; Roberts CJ
    FEBS Lett; 2014 Mar; 588(6):936-41. PubMed ID: 24530501
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Conformational and Colloidal Stabilities of Human Immunoglobulin G Fc and Its Cyclized Variant: Independent and Compensatory Participation of Domains in Aggregation of Multidomain Proteins.
    Yageta S; Shibuya R; Imamura H; Honda S
    Mol Pharm; 2017 Mar; 14(3):699-711. PubMed ID: 28186764
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of Fc N-glycan sialylation on IgG structure.
    Zhang Z; Shah B; Richardson J
    MAbs; 2019; 11(8):1381-1390. PubMed ID: 31411531
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structural characterization of a mutated, ADCC-enhanced human Fc fragment.
    Oganesyan V; Damschroder MM; Leach W; Wu H; Dall'Acqua WF
    Mol Immunol; 2008 Apr; 45(7):1872-82. PubMed ID: 18078997
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stabilisation of the Fc fragment of human IgG1 by engineered intradomain disulfide bonds.
    Wozniak-Knopp G; Stadlmann J; Rüker F
    PLoS One; 2012; 7(1):e30083. PubMed ID: 22272277
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Investigation of the cooperative structure of Fc fragments from myeloma immunoglobulin G.
    Tischenko VM; Abramov VM; Zav'yalov VP
    Biochemistry; 1998 Apr; 37(16):5576-81. PubMed ID: 9548942
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The solution structure of the human IgG2 subclass is distinct from those for human IgG1 and IgG4 providing an explanation for their discrete functions.
    Hui GK; Gardener AD; Begum H; Eldrid C; Thalassinos K; Gor J; Perkins SJ
    J Biol Chem; 2019 Jul; 294(28):10789-10806. PubMed ID: 31088911
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IgG Fc N-glycosylation in Guillain-Barré syndrome treated with immunoglobulins.
    Fokkink WJ; Selman MH; Dortland JR; Durmuş B; Kuitwaard K; Huizinga R; van Rijs W; Tio-Gillen AP; van Doorn PA; Deelder AM; Wuhrer M; Jacobs BC
    J Proteome Res; 2014 Mar; 13(3):1722-30. PubMed ID: 24533874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.